IMEDS: A Collaboration Based on the FDA's Sentinel Initiative
June S. Wasser, MA
Reagan-Udall Foundation for the FDA, United States
This forum will educate industry on how, when, and why, utilizing IMEDS may be helpful to answering drug safety and other types of pharmacovigilance research questions.
Learning Objective : Explain the IMEDS program and the role of the Reagan-Udall Foundation for the FDA; Distinguish the IMEDS database from other safety study databases; Illustrate the purpose and uses of the IMEDS program.
Cheryl Walraven, PhD
Aetna, United States
Jeffrey Brown, PhD, MA
Associate Professor, Department of Population Medicine
Harvard Pilgrim Health Care Institute/Harvard Medical School, United States
Claudia Salinas, PhD
Senior Research Scientist, GPS Pharmacoepidemiology
Eli Lilly and Company, United States